Beiträge

Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination

Dendritic cell therapy of high-grade gliomas

Vaccine therapy in patients with renal cell carcinoma

Postoperative adjuvant dendritic cell-based immunotherapy in patients with relapsed glioblastoma multiforme

Persistent IL-10 production is required for glioma growth suppressive activity by Th1-directed effector cells after stimulation with tumor lysate-loaded dendritic cells

Dendritic cell vaccination in patients with malignant gliomas: current status and future directions

Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study

Transient local response and persistent tumor control in a child with recurrent malignant glioma: treatment with combination therapy including dendritic cell therapy. Case report